Commonwealth Bank of Australia
Commonwealth Bank of Australia (CMWAY) Financial Performance & Income Statement Overview
Explore the financials of Commonwealth Bank of Australia (CMWAY), including yearly and quarterly data on income, cash flow, and balance sheets.
Commonwealth Bank of Australia (CMWAY) Income Statement & Financial Overview
View the income breakdown for Commonwealth Bank of Australia CMWAY across both annual and quarterly reports.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $34.00B | $31.73B | $27.07B | $21.82B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $34.00B | $31.73B | $27.07B | $21.82B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $4.10B | $5.40B | $5.41B | $5.28B |
| Operating Expenses | $2.05B | $1.89B | $2.002B | $1.87B |
| Total Costs & Expenses | $27.19B | $24.53B | $20.30B | $14.13B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $5.79B | $4.87B | $4.15B | $2.81B |
| Depreciation & Amortization | $742.00M | $698.00M | $535.00M | $575.00M |
| EBITDA | $7.51B | $7.84B | -$224.00M | -$398.00M |
| EBITDA Ratio | $0.22 | -$0.01 | -$0.008 | -$0.02 |
| Operating Income | $6.81B | $7.47B | $7.12B | $7.87B |
| Operating Income Ratio | $0.20 | $0.24 | $0.26 | $0.36 |
| Other Income/Expenses (Net) | -$36.00M | -$359.00M | -$352.00M | -$413.00M |
| Income Before Tax | $6.77B | $7.11B | $6.77B | $7.46B |
| Income Before Tax Ratio | $0.20 | $0.22 | $0.25 | $0.34 |
| Income Tax Expense | $2.07B | $2.23B | $1.93B | $2.23B |
| Net Income | $4.65B | $4.76B | $4.98B | $5.14B |
| Net Income Ratio | $0.14 | $0.15 | $0.18 | $0.24 |
| EPS | $2.94 | $2.84 | $2.96 | $3.04 |
| Diluted EPS | $2.78 | $2.82 | $2.80 | $2.84 |
| Weighted Avg Shares Outstanding | $1.67B | $1.67B | $1.69B | $1.70B |
| Weighted Avg Shares Outstanding (Diluted) | $1.77B | $1.79B | $1.78B | $1.81B |
Over the past four quarters, Commonwealth Bank of Australia demonstrated steady revenue growth, increasing from $21.82B in Q2 2023 to $34.00B in Q4 2024. Operating income reached $6.81B in Q4 2024, maintaining a consistent 20% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $7.51B, reflecting operational efficiency. Net income dropped to $4.65B, with EPS at $2.94. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan